Bring your biomedical science to life!
Inspire your audience with BioMation illustrations and animations
- Funding & grant proposals
- Journal articles & covers
- Presentation slides & posters
- Research promotion
- Patient & physician education
- Pharmaceutical communication materials
Links to published images:
Bronwyn A. Kingwell, M. John Chapman, Anatol Kontush, Norman E. Miller. HDL-Targeted Therapies: Progress, Failures and Future
Nature Reviews Drug Discovery. Vol. 13, Issue 6, May 2014, Pages 445–464.
http://www.nature.com/nrd/journal/v13/n6/full/nrd4279.html
Peter J. Meikle, Gerard Wong, Christopher K. Barlow, Bronwyn A.Kingwell. Lipidomics: Potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease. Pharmacology & Therapeutics. Vol. 143, Issue 1, July 2014, Pages 12-23.
http://www.sciencedirect.com/science/article/pii/S0163725814000291
Jennifer A. Ralph, Eric F. Morand. MAPK phosphatase as novel targets for rheumatoid arthritis. Expert Opinion on Therapeutic Targets Vol. 12, No. 7 , July 2008, Pages 795-808.
http://informahealthcare.com/doi/abs/10.1517/14728222.12.7.795%20
Bronwyn A. Kingwell, M. John Chapman, Anatol Kontush, Norman E. Miller. HDL-Targeted Therapies: Progress, Failures and Future
Nature Reviews Drug Discovery. Vol. 13, Issue 6, May 2014, Pages 445–464.
http://www.nature.com/nrd/journal/v13/n6/full/nrd4279.html
Peter J. Meikle, Gerard Wong, Christopher K. Barlow, Bronwyn A.Kingwell. Lipidomics: Potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease. Pharmacology & Therapeutics. Vol. 143, Issue 1, July 2014, Pages 12-23.
http://www.sciencedirect.com/science/article/pii/S0163725814000291
Jennifer A. Ralph, Eric F. Morand. MAPK phosphatase as novel targets for rheumatoid arthritis. Expert Opinion on Therapeutic Targets Vol. 12, No. 7 , July 2008, Pages 795-808.
http://informahealthcare.com/doi/abs/10.1517/14728222.12.7.795%20